Page 1 | Search Results | Blood | American Society of Hematology

1-11 of 11

Sort by

Sort Order Select

Journal Articles

Mutational Analysis of MDS and AML Occurring after Treatment for Acute Promyelocytic Leukemia (APL). a Report of 9 Cases

Philippe Attias, Aline Renneville, MD, Xavier Thomas, MD PhD, Cecile Bally, Sandrine Hayette, Hassan Farhat, MD, Virginie Eclache, MD, Alice Marceau, Bruno Cassinat, PharmD, PhD, Jean Feuillard, MD PhD Pr, Christine Terré, PharmD, PhD, Eric Delabesse, PharmD, PhD, Sophie Park, MD PhD, Julie Lejeune, Sylvie Chevret, MD PhD, Lionel Ades, MD PhD, Claude Preudhomme, MD PhD, Pierre Fenaux, MD PhD

Blood (2016) 128 (22): 2861.

https://doi.org/10.1182/blood.V128.22.2861.2861

Published: 2016

Journal Articles

NOTCH1 Mutations Are Associated With The 14q Deletion In Chronic Lymphocytic Leukemia (CLL) and Small Lymphocytic Lymphoma (SLL)

Blood (2013) 122 (21): 2561.

https://doi.org/10.1182/blood.V122.21.2561.2561

Published: 2013

Journal Articles

Old DAT / New Data : Positive Direct Antiglobulin Test Identifies a Specific Subgroup Of CLL Patients

Anne Quinquenel, MD, Chadi Al Nawakil, MD, Fanny Baran-Marszak, MD, Virginie Eclache, MD, Remi Letestu, MD, Christine Le Roy, PhD, Nadine Varin-Blank, PhD, Alain Delmer, MD, Vincent Levy, MD, PhD, Florence Cymbalista, MD, PhD

Blood (2013) 122 (21): 4154.

https://doi.org/10.1182/blood.V122.21.4154.4154

Published: 2013

Journal Articles

Association Of More Than One B Cell Clone Arises In Any Type Of Leukemic Chronic B Cell Disorder

Gregory Lazarian, Herve Roudot, Riham Farrah, Chadi Al Nawakil, MD, Remi Letestu, MD, Fanny Baran-Marszak, Virginie Eclache, MD, Marouane Boubaya, Alain Delmer, MD, Vincent Levy, MD, PhD, Florence Cymbalista

Blood (2013) 122 (21): 4161.

https://doi.org/10.1182/blood.V122.21.4161.4161

Published: 2013

Journal Articles

Impact Of Cytogenetics and Cytogenetic Response On Outcome In Myelodysplastic Syndromes (MDS) treated With Azacitidine (AZA). A Collaborative Study In 878 Patients

Marie Sebert, Rami S Komrokji, MD, Mikkael A. Sekeres, MD, MS, Thomas Prebet, MD PhD, Thomas Cluzeau, MD, PhD, Valeria Santini, MD, Alessandro Sanna, Najla H Al Ali, Sean Hobson, Virginie Eclache, MD, Alan List, MD, Pierre Fenaux, MD, PhD, Lionel Ades

Blood (2013) 122 (21): 389.

https://doi.org/10.1182/blood.V122.21.389.389

Published: 2013

Journal Articles

Impact of Cytogenetics and Cytogenetic Response On Outcome in MDS Treated with Azacitidine (AZA).

Marie Sebert, Valérie Vidal, Virginie Eclache, MD, Sylvain Thepot, Thorsten Braun, Claude Gardin, Pierre Fenaux, MD, PhD, Lionel Ades, MD, PhD

Blood (2012) 120 (21): 2807.

https://doi.org/10.1182/blood.V120.21.2807.2807

Published: 2012

Journal Articles

Incidence and Prognostic Value of TP53 Mutations in Lower Risk MDS with Del 5q.

Cecile Bally, Lionel Ades, MD, PhD, Aline Renneville, MD, Sophie Raynaud, Virginie Eclache, MD, Thomas Cluzeau, MD, PhD, Mathilde Hunault-Berger, MD, PhD, Aspasia Stamatoullas, MD, Christian Bastard, MD, Michaela Fontenay, MD, PhD, Marie-Joelle Mozziconacci, MD, PhD, Claude Preudhomme, Hugues de The, MD, PhD, Pierre Fenaux, MD, PhD, Jacqueline Lehmann-Che, PharmD, PhD

Blood (2012) 120 (21): 2809.

https://doi.org/10.1182/blood.V120.21.2809.2809

Published: 2012

Journal Articles

SNP-Arrays: a Routine Cytogenetic Tool In Chronic Lymphocytic Leukemia ?.

Alban Godon, MD, Franck Genevieve, MD, Malgorzata Truchan-Graczyk, MD, Laurence Baranger, MD, Virginie Eclache, MD, Anne Coutolleau, Norbert Ifrah, MD, PhD, Marc Zandecki, MD, PhD, Philippe Guardiola, MD

Blood (2010) 116 (21): 4611.

https://doi.org/10.1182/blood.V116.21.4611.4611

Published: 2010

Journal Articles

Randomized Comparison of Imatinib Versus Imatinib Combination Therapies in Newly Diagnosed Chronic Myeloid Leukaemia (CML) Patients in Chronic Phase (CP): First Results of the Phase III (SPIRIT) Trial from the French CML Group (FI LMC)

Blood (2008) 112 (11): 183.

https://doi.org/10.1182/blood.V112.11.183.183

Published: 2008

Journal Articles

Correlations between BCR-ABL Ratio and Cytogenetic Response at Months 12 of the Randomized French SPIRIT Study on Behalf the Fi-LMC Group.

Claude Preudhomme, MD, PhD, Catherine Roche-Lestienne, MD/PHD, Antoine Crinquette, MD, Christophe Roumier, MD/PHD, Virginie Eclache, MD, Joëlle Guilhot, MD, Francois Guilhot, MD/PHD, François-Xavier Mahon, MD/PHD

Blood (2006) 108 (11): 2150.

https://doi.org/10.1182/blood.V108.11.2150.2150

Published: 2006

Journal Articles

Atypical BCR-ABL Transcripts Chronic Myelogenous Leukemias Show Particular Features, and Their Classical Worse Prognosis Seems Abrogated by Imatinib Mesylate. A Retrospective Analysis of 22 Patients, on the Behalf of the French Intergroup of CML (Fi(ϕ)-LMC Group).

Franck E. Nicolini, MD, PhD, Nathalie Grardel, MD, Sandrine Hayette, PhD, Jean-Michel Cayuela, MD, Agnès Buzyn, MD, PhD, Eric Delabesse, MD, Christian Bastard, MD, Odile Blanchet, MD, Nathalie Sorel, PhD, Marie-Josée Mozziconacci, MD, Ali Turhan, MD, PhD, Virginie Eclache, MD, François-Xavier Mahon, MD, PhD, Nicole Dastugue, MD, Eric Legac, MD, Marie-Pierre Gaub, MD, Sélim Corm, MD, Claude Preudhomme, MD, PhD

Blood (2005) 106 (11): 3285.

https://doi.org/10.1182/blood.V106.11.3285.3285

Published: 2005

NARROW

Mutational Analysis of MDS and AML Occurring after Treatment for Acute Promyelocytic Leukemia (APL). a Report of 9 Cases

NOTCH1 Mutations Are Associated With The 14q Deletion In Chronic Lymphocytic Leukemia (CLL) and Small Lymphocytic Lymphoma (SLL)

Old DAT / New Data : Positive Direct Antiglobulin Test Identifies a Specific Subgroup Of CLL Patients

Association Of More Than One B Cell Clone Arises In Any Type Of Leukemic Chronic B Cell Disorder

Impact Of Cytogenetics and Cytogenetic Response On Outcome In Myelodysplastic Syndromes (MDS) treated With Azacitidine (AZA). A Collaborative Study In 878 Patients

Impact of Cytogenetics and Cytogenetic Response On Outcome in MDS Treated with Azacitidine (AZA).

Incidence and Prognostic Value of TP53 Mutations in Lower Risk MDS with Del 5q.

SNP-Arrays: a Routine Cytogenetic Tool In Chronic Lymphocytic Leukemia ?.

Randomized Comparison of Imatinib Versus Imatinib Combination Therapies in Newly Diagnosed Chronic Myeloid Leukaemia (CML) Patients in Chronic Phase (CP): First Results of the Phase III (SPIRIT) Trial from the French CML Group (FI LMC)

Correlations between BCR-ABL Ratio and Cytogenetic Response at Months 12 of the Randomized French SPIRIT Study on Behalf the Fi-LMC Group.

Atypical BCR-ABL Transcripts Chronic Myelogenous Leukemias Show Particular Features, and Their Classical Worse Prognosis Seems Abrogated by Imatinib Mesylate. A Retrospective Analysis of 22 Patients, on the Behalf of the French Intergroup of CML (Fi(ϕ)-LMC Group).

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only